Greater absolute risk for all subtypes of breast cancer in the US than Malaysia

Breast Cancer Research and Treatment

Volumn 149, Issue 1, 2015, Pages 285-291

  Horne, Hisani N ^a   Beena Devi, C R ^b   Sung, Hyuna ^a   Tang, Tieng Swee ^b   Rosenberg, Philip S ^a   Hewitt, Stephen M ^a   Sherman, Mark E ^a   Anderson, William F ^a   Yang, Xiaohong R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SARAWAK GENERAL HOSPITAL   (Malaysia)

Author keywords

Breast cancer; Incidence rates; Intrinsic subtypes; SEER

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MIDDLE AGED; POPULATION RISK; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; UNITED STATES; ASIAN CONTINENTAL ANCESTRY GROUP; BIOSYNTHESIS; BREAST NEOPLASMS; CANCER REGISTRY; CAUCASIAN; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALAYSIA; RECEPTORS, ESTROGEN; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84925511073     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3243-9     Document Type: Article

References (24)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. doi:10.1002/ijc.25516
2. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer rates in different geographic regions of the world. J Clin Oncol 24(14):2137–2150
3. Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncology 13(8):790–801. doi:10.1016/S1470-2045(12)70211-5
4. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27(27):4515–4521. doi:10.1200/JCO.2008.19.6873
5. Bhikoo R, Srinivasa S, Yu TC, Moss D, Hill AG (2011) Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, Eastern Europe, Mexico, the Caribbean and South America. Cancers 3(2):2358–2381. doi:10.3390/cancers3022358
6. Bhikoo R, Srinivasa S, Yu TC, Moss D, Hill AG (2011) Systematic review of breast cancer biology in developing countries (part 2): Asian subcontinent and South East Asia. Cancers 3(2):2382–2401. doi:10.3390/cancers3022382
7. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, Cronin KA (2014) US Incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106(5):dju055
8. SEER-18 (2014) Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (2000-2011) < Katrina/Rita Population Adjustment > - Linked To County Attributes - Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2014), based on the November 2013 submission. www.seer.cancer.gov
9. Devi CR, Tang TS, Corbex M (2012) Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak. Malaysia. Int J Cancer 131(12):2869–2877. doi:10.1002/ijc.27527
10. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752
11. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14):8418–8423
12. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10(16):5367–5374
13. Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV Jr (2012) Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 104(14):1094–1101. doi:10.1093/jnci/djs264
14. Anderson WF, Katki HA, Rosenberg PS (2011) Breast cancer incidence in the United States: current and future trends. J Natl Cancer Inst 103(18):1397–1402. doi:10.1093/jnci/djr257
15. Gomez SL, Quach T, Horn-Ross PL, Pham JT, Cockburn M, Chang ET, Keegan TH, Glaser SL, Clarke CA (2010) Hidden breast cancer disparities in asian women: disaggregating incidence rates by ethnicity and migrant status. Am J Public Health 100(Suppl 1):S125–S131. doi:10.2105/AJPH.2009.163931
16. Yau TK, Sze H, Soong IS, Hioe F, Khoo US, Lee AW (2008) HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in situ hybridisation assays. Hong Kong Acad Med 14(2):130–135
17. Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, Fu L (2009) Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol 100(2):89–94. doi:10.1002/jso.21307
18. Tan YO, Han S, Lu YS, Yip CH, Sunpaweravong P, Jeong J, Caguioa PB, Aggarwal S, Yeoh EM, Moon H (2010) The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey. Cancer 116(23):5348–5357. doi:10.1002/cncr.25476
19. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Bernstein L (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women’s contraceptive and reproductive experiences study. Cancer Res 70(2):575–587. doi:10.1158/0008-5472.CAN-09-3460
20. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574
21. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91(23):2020–2028
22. Palmer JR, Viscidi E, Troester MA, Hong CC, Schedin P, Bethea TN, Bandera EV, Borges V, McKinnon C, Haiman CA, Lunetta K, Kolonel LN, Rosenberg L, Olshan AF, Ambrosone CB (2014) Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER consortium. J Natl Cancer Inst. doi:10.1093/jnci/dju237
23. McCormack VA, Joffe M, van den Berg E, Broeze N, Silva Idos S, Romieu I, Jacobson JS, Neugut AI, Schuz J, Cubasch H (2013) Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res 15(5):R84. doi:10.1186/bcr3478
24. Stark A, Kleer CG, Martin I, Awuah B, Nsiah-Asare A, Takyi V, Braman M, Quayson SE, Zarbo R, Wicha M, Newman L (2010) African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 116(21):4926–4932. doi:10.1002/cncr.25276